Abstract
Bladder cancer is one of the most common cancers of the urinary tract, and it is a highly fatal disease with frequent recurrence and progression. Therefore, there is an urgent need for gaining an understanding of the exact pathophysiology of bladder cancer, as well as for developing new and effective treatment modalities. While many challenging scientific questions are still unanswered, major advances in molecular biology and cancer genetics have greatly increased the knowledge of molecular mechanisms involved in cancer development and progression, leading to significant advances in the treatment of bladder cancer over the last decade.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
